0001181431-14-034523.txt : 20141020
0001181431-14-034523.hdr.sgml : 20141020
20141020200828
ACCESSION NUMBER: 0001181431-14-034523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141016
FILED AS OF DATE: 20141020
DATE AS OF CHANGE: 20141020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXACT SCIENCES CORP
CENTRAL INDEX KEY: 0001124140
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 204782291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
BUSINESS PHONE: 608-284-5700
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
FORMER COMPANY:
FORMER CONFORMED NAME: EXACT CORP
DATE OF NAME CHANGE: 20000919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIDGARD GRAHAM PETER
CENTRAL INDEX KEY: 0001216274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35092
FILM NUMBER: 141164764
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
4
1
rrd417743.xml
OCTOBER 10B5-1 SALES
X0306
4
2014-10-16
0
0001124140
EXACT SCIENCES CORP
EXAS
0001216274
LIDGARD GRAHAM PETER
C/O EXACT SCIENCES CORP.
441 CHARMANY DRIVE
MADISON
WI
53719
0
1
0
0
Chief Science Officer
Common Stock
2014-10-16
4
M
0
50000
2.88
A
167783
D
Common Stock
2014-10-16
4
S
0
50000
22.8418
D
117783
D
Common Stock
2014-10-17
4
M
0
50000
2.88
A
167783
D
Common Stock
2014-10-17
4
S
0
50000
23.6823
D
117783
D
Common Stock
2014-10-20
4
M
0
50000
2.88
A
167783
D
Common Stock
2014-10-20
4
S
0
50000
23.9323
D
117783
D
Common Stock
2014-10-20
4
M
0
75000
2.88
A
192783
D
Common Stock
11395
I
Held in 401(K) Account
Stock Option (right to buy)
2.88
2014-10-16
4
M
0
50000
0
D
2013-08-03
2019-08-03
Common Stock
600000
550000
D
Stock Option (right to buy)
2.88
2014-10-17
4
M
0
50000
0
D
2013-08-03
2019-08-03
Common Stock
550000
500000
D
Stock Option (right to buy)
2.88
2014-10-20
4
M
0
50000
0
D
2013-08-03
2019-08-03
Common Stock
500000
450000
D
Stock Option (right to buy)
2.88
2014-10-20
4
M
0
75000
0
D
2013-08-03
2019-08-03
Common Stock
450000
375000
D
The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
/s/ Graham P. Lidgard by Mark R. Busch, attorney-in-fact
2014-10-20